(Q44712409)

5 December 2017

title

C-peptide determination in the choice of treatment in diabetes mellitus (English)

1 reference

5 December 2017

Koskinen P

1

1 reference

5 December 2017

Viikari J

2

1 reference

5 December 2017

Irjala K

3

1 reference

5 December 2017

Kaihola HL

4

1 reference

5 December 2017

Seppälä P

5

1 reference

5 December 2017

publication date

1 November 1985

1 reference

Scandinavian Journal of Clinical and Laboratory Investigation

5 December 2017

published in

1 reference

5 December 2017

volume

45

1 reference

5 December 2017

issue

7

1 reference

5 December 2017

page(s)

589-597

1 reference

Residual Beta-cell Function and Its Metabolic Consequences

5 December 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F00365518509155265

Metabolic Control in Diabetic Patients: Effect of Insulin-secretory Reserve (Measured by Plasma C-Peptide Levels) and Circulating Insulin Antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365518509155265

Human C-peptide in normal and diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365518509155265

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365518509155265

Plasma C-peptide in uraemic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365518509155265

C-Peptide reserve in insulin-dependent diabetes. Comparative responses to glucose, glucagon and tolbutamide

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365518509155265

Prevalence of residual B-cell function in insulin-treated diabetics evaluated by the plasma C-peptide response to intravenous glucagon

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365518509155265

Correlation between fasting serum C-peptide and B cell insulin secretory capacity in diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365518509155265

C-peptide Response to Glucagon: A Test for the Residual β-cell Function in Diabetes Mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365518509155265

C-Peptide Levels as a Criterion in Treatment of Maturity-Onset Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365518509155265

Importance of fasting plasma glucose concentration and obesity in the interpretation of fasting serum C-peptide values.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365518509155265

Factors affecting fasting serum C-peptide levels in Micronesians: comparison with a Caucasoid population.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365518509155265

Characterization of seven C-peptide antisera

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365518509155265

10.3109/00365518509155265

21 January 2018

Identifiers

DOI

1 reference

5 December 2017

1 reference